Schedule 13G ownership disclosure
Avidity Biosciences Inc
COMMON STOCK · CUSIP: 05370A108
Event date: 2025-12-31
- Filing-level shares
- 142,888
- Percent of class
- 0.1%
- T. Rowe Price Associates, Inc.
Shares: 142,888 · Class: 0.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-26-000279
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Biosciences, Inc.
- CIK
- CIK 1599901
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership